Editorial to the Special Issue "Lipidomics and Neurodegenerative Diseases"

Int J Mol Sci. 2021 Jan 28;22(3):1270. doi: 10.3390/ijms22031270.

Abstract

The contribution of dysregulation of lipid signaling and metabolism to neurodegenerative diseases including Alzheimer's and Parkinson's is the focus of this special issue. Here, the matter of three reviews and one research article is summarized.

Keywords: biomarker; lipidomics; mass spectrometry; neurodegenerative diseases; sphingolipid.

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / genetics
  • Amyloid beta-Peptides / metabolism
  • Biomarkers / metabolism
  • Brain / metabolism*
  • Brain / pathology
  • Cerebrosides / metabolism
  • Gene Expression Regulation
  • Humans
  • Lipid Metabolism*
  • Lipidomics / methods*
  • Mass Spectrometry
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology
  • Sphingolipids / metabolism
  • Sphingomyelins / metabolism
  • tau Proteins / genetics
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • Biomarkers
  • Cerebrosides
  • MAPT protein, human
  • MicroRNAs
  • Sphingolipids
  • Sphingomyelins
  • tau Proteins